Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases. It develops ImmTAC (Immune Mobilizing Monoclonal TCRs Against Cancer) molecules, ImmTAV and ImmTAB (Immune Mobilizing Monoclonal TCRs Against Virus or Bacteria) molecules, and ImmTAAI (Immune Mobilizing Monoclonal TCRs Against Autoimmune Disease) molecules. The company uses human TCRs to overcome the limitations of a natural immune system and current therapeutic approaches through engineering bispecific.
|Company Name||Date||Deal Size|
|Immunocore Commercial LLC|
|Immunocore Ireland Limited|
|Immunocore Nominees Limited|
Immunocore revenue breakdown by business segment: 22.4% from GlaxoSmithKline, 74.4% from Genentech and 3.2% from Other
Immunocore revenue breakdown by geographic segment: 22.4% from United Kingdom and 77.6% from United States
Immunocore has 2.68k Twitter Followers. The number of followers has increased 0.8% month over month and increased 2.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Immunocore founded?
Immunocore was founded in 2008.
Who are Immunocore key executives?
Immunocore's key executives are Bahija Jallal, Brian di Donato and Frankie Webster.
How many employees does Immunocore have?
Immunocore has 291 employees.
What is Immunocore revenue?
Latest Immunocore annual revenue is $30.1 m.
What is Immunocore revenue per employee?
Latest Immunocore revenue per employee is $103.5 k.
Who are Immunocore competitors?
Competitors of Immunocore include LogicBio Therapeutics, Fab'entech and Maverick Therapeutics.
Where is Immunocore headquarters?
Immunocore headquarters is located at 92 Park Dr, Milton.
Where are Immunocore offices?
Immunocore has offices in Milton, Conshohocken and Rockville.
How many offices does Immunocore have?
Immunocore has 3 offices.
Receive alerts for 300+ data fields across thousands of companies